Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 2c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance
• Canaccord Downgrades Flight Center Travel Group Ltd (FLT:AU) (FGETF) to Hold
• CrowdStrike shares jump on earnings beat, raised outlook